Condition
Alcohol Abuse
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 31 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
31 shownThe Effect of Comorbid Alcohol/Substance UseNCT07692984 · 2026-06-20
RECRUITINGReducing Hazardous Alcohol Use and Optimizing Treatment as Prevention Among Men Living With HIV in Risk EnvironmentsNCT06771843 · 2025-06-16
RECRUITINGAn Economic and Relationship-strengthening Intervention to Reduce Alcohol Use in MalawiNCT06367348 · 2025-02-14
RECRUITINGProject SPACE: Testing Daily Text Messages to Reduce Alcohol Use and HIV Risk BehaviorNCT07769580 · 2027-02-01
NOT_YET_RECRUITINGTeam-based Learning Intervention to Prevent Risk Factors for Chronic Diseases - a Cluster Randomized TrialNCT06894134 · 2025-09-01
NOT_YET_RECRUITINGDoes Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?NCT05895643 · 2023-06-13
COMPLETEDCouple-Based Motivational Interviewing With Mobile Breathalyzers to Reduce Alcohol Use in South AfricaNCT05756790 · 2023-03-15
COMPLETEDAn Economic and Relationship-strengthening Intervention for HIV-affected Couples Who Drink Alcohol in MalawiNCT04906616 · 2021-05-31
COMPLETEDBuilding Mobile HIV Prevention and Mental Health Support in Low-resource SettingsNCT03912753 · 2019-05-20
COMPLETEDSkills-training for Reducing Risky Alcohol Use in App FormNCT03696888 · 2018-12-07
COMPLETEDComputer-based Intervention for Alcohol-using HIV/HCV+ WomenNCT03362476 · 2018-01-03
COMPLETEDBrief Electronic Intervention for Heavy Drinking and Sex Risk Among MSM Seeking HIV TestingNCT03435783 · 2017-10-13
COMPLETEDAlcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT)NCT03302299 · 2017-04-07
COMPLETEDAripiprazole for Bipolar Disorder and Alcohol Use DisorderNCT02918370 · 2016-11-01
COMPLETEDProject ACTIVE a Clinical InterventionNCT04211883 · 2016-01-20
COMPLETEDReducing Problematic Substance Use in Youth With Chronic Medical ConditionsNCT01709201 · 2013-07-01
WITHDRAWNContingency Management of Alcohol Abuse in the Severely Mentally ILLNCT01567943 · 2012-03-01
COMPLETEDBehavioral Counseling Intervention Trial to Reduce Alcohol-related Sexual Risk Behavior Among HIV-negative Men in NamibiaNCT02359487 · 2011-02-01
COMPLETEDOndansetron, Alcohol Use, and Alcohol-Related Symptoms In HIV+ PersonsNCT01254877 · 2010-12-01
COMPLETEDCognitive Behavioral Treatment to Reduce Alcohol Use Among HIV-Infected KenyansNCT00792519 · 2009-02-01
COMPLETEDAlcohol, Suicide and HIV Prevention for Teens in Mental Health TreatmentNCT02228044 · 2008-09-01
COMPLETEDBone Density in Patients With SchizophreniaNCT00540267 · 2007-11-01
COMPLETEDAcamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and AlcoholismNCT00452543 · 2007-03-01
COMPLETEDReducing Unsafe Alcohol Use in HIV-Positive IndividualsNCT00371969 · 2006-10-01
COMPLETEDRisperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use DisorderNCT00130923 · 2005-09-01
COMPLETEDStudy Comparing Two Types of Psychotherapy for Treating Depression and Substance AbuseNCT00108407 · 2004-10-01
COMPLETEDEfficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use DisorderNCT00156715 · 2004-03-01
COMPLETEDAlcohol Use Disorders in SchizophreniaNCT00280813 · 2004-03-01
COMPLETEDNaltrexone Treatment of Alcohol Abuse in SchizophreniaNCT00145847 · 2003-04-01
COMPLETEDCognitive Behavioral Stress Management for HIV+ Drug AbusersNCT00722644 · 1999-09-01
COMPLETEDAlcoholism and Schizophrenia: Effects of ClozapineNCT00169026 · 1999-05-01
TERMINATEDCommon interventions
PlaceboDRUG3MlambeBEHAVIORAL2Motivational InterviewingBEHAVIORAL2acamprosateDRUG1ACTIVE interventionBEHAVIORAL1Alcohol-HIV Risk Reduction CounselingBEHAVIORAL1AripiprazoleDRUG1Attention-Matched ControlBEHAVIORAL1Behavioral EconomicsBEHAVIORAL1Brief clinician-delivered METBEHAVIORAL1Brief Electronic InterventionBEHAVIORAL1Brief InterventionBEHAVIORAL1case (comorbid diagnosis)OTHER1CBTBEHAVIORAL1Clozapine versus typical (conventional) and atypical antipsychotic medicationsDRUG1CLT- Abstract text messagesBEHAVIORAL1CLT- Concrete text messagesBEHAVIORAL1Cognitive Behavioral Stress ManagementBEHAVIORAL1Computer-based alcohol reduction interventionBEHAVIORAL1ComunicăBEHAVIORAL1Contingency ManagementBEHAVIORAL1controlOTHER1Control messagesBEHAVIORAL1Education Attention ControlOTHER1Enhanced Motivational InterviewBEHAVIORAL1
Leading sponsors
University of California, San Francisco
4
Dartmouth-Hitchcock Medical Center
3
Brown University
2
Abant Izzet Baysal University
1
Boston Children's Hospital
1
Centers for Disease Control and Prevention
1
Columbia University
1
Emory University
1
George Mason University
1
Inje University
1
Johns Hopkins University
1
Karolinska Institutet
1
Massachusetts General Hospital
1
National Institute on Drug Abuse (NIDA)
1
New York University
1
Trial status mix
COMPLETED24
RECRUITING3
NOT_YET_RECRUITING2
TERMINATED1
WITHDRAWN1
Phase mix
NA18
PHASE46
PHASE12
PHASE22
PHASE31
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.